Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.
about
Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsAntibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsImmunosuppressive T cell antibody induction therapy for liver transplant recipientsCyclosporin versus tacrolimus for liver transplanted patientsCurrent status of paediatric heart, lung, and heart-lung transplantationCurrent status of immunosuppression in liver transplantationMetabolic and cardiovascular complications in the liver transplant recipientEffect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver TransplantationSirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results.Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study.Biliary atresia: recent progress.In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.Late-onset acute rejection after living donor liver transplantation.Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation.Intensive care management of liver transplanted patients.Developments in liver transplantation.Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantationAssessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status.Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver TransplantCyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.Critical care issues in adult liver transplantation.Risk of bladder cancer in renal transplant recipients: a meta-analysis.Tacrolimus in the treatment of ocular diseases.Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences.Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.The role of biologic agents in the management of non-infectious uveitis.Immunomodulating options for liver transplant patients.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.What is the best immunosuppressant combination in terms of antitumor effect in hepatocellular carcinoma?Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis.Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
P2860
Q24194087-DA50F175-0999-409F-BDAD-72066C1D851FQ24194518-643AC399-4A01-4C32-B2D2-B0DE071F0EF7Q24197745-A73E26ED-81BB-4205-8602-5A61DD08747BQ24197859-860159E6-C715-40C4-BC6C-E4C9EDE520D5Q24235428-9DEB27A9-3CDB-45CA-82C2-00AD3A63A45EQ24244114-40DA919A-461F-4A6A-ACD4-2C05E4344897Q24675133-A7679B56-6766-45A4-B03D-47E6AAF582B4Q27694591-A4DF2BDE-484B-4DAF-A899-30830FB6D42CQ28082243-F106FE64-6DD1-4855-A16B-C22449DEB976Q28548318-D81BC959-CD73-49E8-B979-3933BA6394EAQ33376348-6D48FD07-0F76-4221-B98B-62564D0330A6Q33394798-6E21C4C6-C685-438A-A8F2-BFCC8B671316Q33670749-8C807EF1-1799-4178-A4F1-84BD7317C3FFQ33962560-7279A08A-5742-43C8-AF3A-4BC655F5B41BQ34017762-38AAE6BB-133C-434D-BF69-8ECC930DAAC0Q34093890-1259B471-F27B-45C0-97BC-6B60EA133A72Q34779162-8EF6F462-E2F6-4582-8FCC-0E3639205255Q35596527-081D9CAD-92B7-479F-893A-CBEC7045F9EDQ35836067-160708E3-9AF1-4F7E-9616-92AED09E33C2Q35860203-C03F07F6-38BE-4EA9-ABB8-71479C1451DAQ36073213-E8DD1FEE-0817-4EC4-AD56-89B675B2C3E6Q36091792-4CB74DA9-444E-4B80-9F02-E5BF1D58DAE5Q36182011-1EB00154-496E-495D-B55C-E51C81A2EF2BQ36530398-B36842F4-170F-4670-AF37-699345E7646EQ36603215-09023384-9778-48D9-8EBD-2C912E3E47F1Q37343317-E2B45211-1345-476E-ACCE-08B7580975DEQ37439861-B546943E-F94B-4269-885C-68C593E8942EQ37664371-8700416D-D4A2-459B-BB1F-17576B2E25E5Q37681727-145AC6A5-A086-4168-88CC-35CB9F476E26Q37858514-1D962DCF-761C-40D5-8816-2E68F4E14A5DQ37962197-9773D627-7405-4F84-BEEE-9F95876A3428Q38019054-4513EDE8-FDEE-4602-B16F-9587FB4DE3E4Q38025152-8E453411-DD8D-4A9D-B560-DB035CC5F481Q38044761-B5185D9B-3863-4B7E-BD7E-CE9DC8EEE61EQ38737314-B193AAE1-1D8B-4BB9-8C09-1A7884839147Q38786418-8C0698C1-7C50-48C1-8572-707C0D8AC80CQ38837109-3590C7E6-D44E-4433-9C49-72C5FEB1BD22Q38904800-AEEDD633-22AA-477A-AFAC-D7EE95ABA90CQ39022568-B234AFE2-A3B7-437E-A13B-ECC5694690F2Q39968802-170D4A06-683E-4993-80DD-6780E0289589
P2860
Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@ast
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@en
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@nl
type
label
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@ast
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@en
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@nl
prefLabel
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@ast
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@en
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@nl
P2093
P1433
P1476
Tacrolimus versus microemulsif ...... C randomised controlled trial.
@en
P2093
A Burroughs
A Truesdale
D Elbourne
J G O'Grady
UK and Republic of Ireland Liver Transplant Study Group
P304
P356
10.1016/S0140-6736(02)11196-2
P407
P577
2002-10-01T00:00:00Z